|
OMIM |
Link |
Information gain |
01 |
|
alport syndrome, autosomal dominant
|
[NCBI]
|
0.00469116
|
|
|
SLE
|
[NCBI]
|
0.00260982
|
|
|
renal failure, progressive, with hypertension
|
[NCBI]
|
0.00213661
|
|
|
SLEN3
|
[NCBI]
|
0.000832846
|
|
|
SLEN2
|
[NCBI]
|
0.000832846
|
|
|
SLEN1
|
[NCBI]
|
0.000832846
|
|
|
IGAN1
|
[NCBI]
|
0.000377429
|
|
|
MYH9
|
[NCBI]
|
0.000216267
|
|
|
charcot-marie-tooth disease and deafness
|
[NCBI]
|
0.000152176
|
|
|
ATS
|
[NCBI]
|
0.000145686
|
|
|
COL4A5
|
[NCBI]
|
0.000139211
|
|
|
epstein syndrome
|
[NCBI]
|
0.000129648
|
|
|
SBS
|
[NCBI]
|
0.000129648
|
|
|
FTNS
|
[NCBI]
|
0.000116582
|
|
|
MHA
|
[NCBI]
|
9.7771e-05
|
|
|
RA
|
[NCBI]
|
9.49401e-05
|
|
|
COL4A3
|
[NCBI]
|
8.62682e-05
|
|
|
megsin
|
[NCBI]
|
7.91621e-05
|
|
|
rheumatic fever-related antigen
|
[NCBI]
|
6.0527e-05
|
|
|
NPTX2
|
[NCBI]
|
5.68123e-05
|
|
|
NPHP3
|
[NCBI]
|
5.62157e-05
|
|
|
hyperprolinemia, type i
|
[NCBI]
|
5.00471e-05
|
|
|
COL4A4
|
[NCBI]
|
4.92232e-05
|
|
|
muckle-wells syndrome
|
[NCBI]
|
4.66247e-05
|
|
|
PHA1
|
[NCBI]
|
4.56329e-05
|
|
|
erythermalgia, primary
|
[NCBI]
|
4.47009e-05
|
|
|
PIGR
|
[NCBI]
|
3.8347e-05
|
|
|
IGHG1
|
[NCBI]
|
3.75072e-05
|
|
|
CTGF
|
[NCBI]
|
3.69716e-05
|
|
|
ENPEP
|
[NCBI]
|
3.67339e-05
|
|
|
NPHP1
|
[NCBI]
|
3.64992e-05
|
|
|
complement component 2 deficiency
|
[NCBI]
|
3.63691e-05
|
|
|
bartter syndrome, type 3
|
[NCBI]
|
3.54798e-05
|
|
|
VASP
|
[NCBI]
|
3.50327e-05
|
|
|
XDH
|
[NCBI]
|
3.42779e-05
|
|
|
C3
|
[NCBI]
|
3.41386e-05
|
|
|
MPO
|
[NCBI]
|
3.34663e-05
|
|
|
HGF
|
[NCBI]
|
2.74669e-05
|
|
|
PNMT
|
[NCBI]
|
2.70209e-05
|
|
|
SPP1
|
[NCBI]
|
2.68458e-05
|
|
|
MTTL1
|
[NCBI]
|
2.58732e-05
|
|
|
MBL2
|
[NCBI]
|
1.558e-05
|
|
|
PCNA
|
[NCBI]
|
1.48648e-05
|
|
|
GAPDH
|
[NCBI]
|
1.27444e-05
|
|
|
PF4
|
[NCBI]
|
1.21506e-05
|
|
|
FRAP1
|
[NCBI]
|
1.12386e-05
|
|
|
TNF
|
[NCBI]
|
4.65304e-06
|
|
|
TNFSF6
|
[NCBI]
|
4.61983e-06
|
|
|
LPL
|
[NCBI]
|
2.88375e-06
|
|
|
polycystic kidneys
|
[NCBI]
|
2.74466e-06
|
|
|
PTH
|
[NCBI]
|
1.37634e-06
|
|
|
VEGF
|
[NCBI]
|
1.03262e-06
|
|
|
AVP
|
[NCBI]
|
1.02285e-06
|
|
|
EGF
|
[NCBI]
|
9.69231e-07
|
|
|
KLK3
|
[NCBI]
|
7.64544e-07
|
|
|
EPO
|
[NCBI]
|
2.49074e-07
|
|